These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
911 related articles for article (PubMed ID: 17369508)
1. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508 [TBL] [Abstract][Full Text] [Related]
2. Redox activated MAP kinase death signaling cascade initiated by ASK1 is not activated in female mice following MPTP: novel mechanism of neuroprotection. Saeed U; Karunakaran S; Meka DP; Koumar RC; Ramakrishnan S; Joshi SD; Nidadavolu P; Ravindranath V Neurotox Res; 2009 Aug; 16(2):116-26. PubMed ID: 19526288 [TBL] [Abstract][Full Text] [Related]
3. MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model. Ray A; Sehgal N; Karunakaran S; Rangarajan G; Ravindranath V Free Radic Biol Med; 2015 Oct; 87():312-25. PubMed ID: 26164633 [TBL] [Abstract][Full Text] [Related]
4. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042 [TBL] [Abstract][Full Text] [Related]
5. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease. Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516 [TBL] [Abstract][Full Text] [Related]
6. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease. Ray A; Kambali M; Ravindranath V Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974 [TBL] [Abstract][Full Text] [Related]
7. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023 [TBL] [Abstract][Full Text] [Related]
8. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638 [TBL] [Abstract][Full Text] [Related]
10. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. Saporito MS; Thomas BA; Scott RW J Neurochem; 2000 Sep; 75(3):1200-8. PubMed ID: 10936203 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
13. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Junn E; Taniguchi H; Jeong BS; Zhao X; Ichijo H; Mouradian MM Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9691-6. PubMed ID: 15983381 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra. Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869 [TBL] [Abstract][Full Text] [Related]
16. Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF. Patel D; Jana A; Roy A; Pahan K J Neuroimmune Pharmacol; 2019 Sep; 14(3):503-518. PubMed ID: 31119595 [TBL] [Abstract][Full Text] [Related]
17. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease. Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678 [TBL] [Abstract][Full Text] [Related]
18. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. Khasnavis S; Pahan K J Neuroimmune Pharmacol; 2014 Sep; 9(4):569-81. PubMed ID: 24946862 [TBL] [Abstract][Full Text] [Related]
19. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism. Park G; Park YJ; Yang HO; Oh MS Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986 [TBL] [Abstract][Full Text] [Related]
20. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. Mandel S; Maor G; Youdim MB J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]